374Water director buys $25K convertible note
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
374Water Inc. (SCWO) director James Pawloski reported acquiring a $50,000-principal 10% secured convertible note and a warrant for 10,000 common shares on March 11, 2026, in a private placement. The note was purchased at 100% of principal, and the warrant was issued with it for no separate consideration.
On May 29, 2026, the issuer amended those securities: the note’s conversion price changed from $5.00 to $3.00 per share, and the warrant’s exercise price from $7.50 to $4.50, while warrant coverage increased from 10,000 to 16,667 shares. The original instruments were reported as deemed canceled and the amended instruments acquired; no additional consideration was paid. On November 2, 2026, Pawloski acquired a $25,000-principal note and a warrant for 8,333 shares.
The Notes bear 10% annual interest, and the Warrants are exercisable for cash only. On September 30, 2026, $2,780.82 of deferred interest was added to the March note’s principal, but that amount is excluded from the principal and underlying-share figures reported. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | 10% Secured Convertible Note F1, F2, F3 | 25,000 | $25,000.00 as filed | -- |
| Grant/Award | Warrant (right to buy) F4, F2 | 8,333 | $0.00 | $0.00 |
| Disposition | 10% Secured Convertible Note F5, F3 | 50,000 | -- | -- |
| Grant/Award | 10% Secured Convertible Note F5, F3 | 50,000 | -- | -- |
| Disposition | Warrant (right to buy) F5 | 10,000 | -- | -- |
| Grant/Award | Warrant (right to buy) F5 | 16,667 | -- | -- |
| Grant/Award | 10% Secured Convertible Note F1, F2 | 50,000 | $50,000.00 as filed | -- |
| Grant/Award | Warrant (right to buy) F4, F2 | 10,000 | $0.00 | $0.00 |
- 10% Secured Convertible Note, Nov 2, 2026. Price shown as filed: $25,000.00 per share is far above the $2.54 close on Nov 2, 2026, so no transaction value is shown.
- 10% Secured Convertible Note, Mar 11, 2026. Price shown as filed: $50,000.00 per share is far above the $2.60 close on Mar 11, 2026, so no transaction value is shown.
Footnotes (5)
- F1. The reporting person acquired the Issuer's 10% Secured Convertible Notes (the "Notes") and the related common stock purchase warrants (the "Warrants") from the Issuer in a private placement. The reporting person's participation was approved in advance by the Issuer's Board of Directors, and the acquisition is exempt under Rule 16b-3(d). The Notes are reported by principal amount.
- F2. The Notes were purchased at 100% of their principal amount. The Warrants were issued together with the Notes for no separate consideration.
- F3. The Notes bear interest at 10% per annum and are convertible, at the holder's option, into common stock at any time before the close of business on the third scheduled trading day preceding the maturity date, which is three years from the date of issuance. The number of underlying shares is the principal amount divided by the conversion price, rounded to the nearest whole share, and excludes accrued and unpaid interest, which is also convertible at the conversion price. On September 30, 2026, $2,780.82 of deferred interest was added to the principal amount of the Note issued on March 11, 2026; that amount is not included in the principal amount or underlying shares reported above.
- F4. The Warrants are exercisable for cash only, beginning on the date of issuance and expiring three years thereafter. The number of Warrant shares equals 100% of the shares underlying the related Note, rounded to the nearest whole share.
- F5. On May 29, 2026, the Issuer amended all outstanding Notes and Warrants issued in the private placement, on the same terms for all holders, to reduce the conversion price of the Notes from $5.00 to $3.00 per share, to reduce the exercise price of the Warrants from $7.50 to $4.50 per share, and to increase the number of shares issuable under each Warrant to maintain 100% coverage of the shares underlying the related Note (for the reporting person, from 10,000 to 16,667 shares). No additional consideration was paid. The amendment was approved by the Issuer's Board of Directors and is reported as the deemed cancellation of the original Note and Warrant and the acquisition of the amended Note and Warrant, exempt under Rule 16b-3(e) and Rule 16b-3(d), respectively
Key Figures
Key Terms
10% Secured Convertible Notes financial
private placement financial
principal amount financial
deferred interest financial
third scheduled trading day technical
deemed cancellation technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did James Pawloski acquire from 374Water (SCWO) on November 2, 2026?
What changed in the 374Water (SCWO) note and warrant amendment on May 29, 2026?
What are the conversion and interest terms of 374Water (SCWO) Notes?
AI-generated analysis. How Rhea-AI works. Not financial advice.